These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10746444)

  • 1. Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis.
    Avisar R; Robinson A; Appel I; Yassur Y; Weinberger D
    Cornea; 2000 Mar; 19(2):145-7. PubMed ID: 10746444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the topical treatment with NSAIDs on corneal sensitivity and ocular surface of Sjögren's syndrome patients.
    Aragona P; Stilo A; Ferreri F; Mobrici M
    Eye (Lond); 2005 May; 19(5):535-9. PubMed ID: 15184937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two different formulations of diclofenac sodium 0.1% in the treatment of inflammation following cataract-intraocular lens surgery.
    Mester U; Lohmann C; Pleyer U; Steinkamp G; Völcker E; Kruger H; Raj PS
    Drugs R D; 2002; 3(3):143-51. PubMed ID: 12099157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filamentary keratitis.
    Hamilton W; Wood TO
    Am J Ophthalmol; 1982 Apr; 93(4):466-9. PubMed ID: 7072810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ocular tolerability between preserved and preservative-free diclofenac sodium drops.
    Moisseiev E; Varssano D
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):333-7. PubMed ID: 21702687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratitis associated with presumed polyendocrinopathy syndrome: treatment with fluorometholone and diclofenac sodium.
    Des Marchais B; Bazin R
    Can J Ophthalmol; 1995 Dec; 30(7):380-4. PubMed ID: 8963942
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis.
    Brignole F; Pisella PJ; Dupas B; Baeyens V; Baudouin C
    Graefes Arch Clin Exp Ophthalmol; 2005 Jun; 243(6):531-8. PubMed ID: 15965673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial.
    Colin J; Paquette B
    Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diclofenac sodium 0.1% ophthalmic solution in the treatment of ocular symptoms after bilateral radial keratotomy.
    Hettinger ME; Gill DJ; Robin JB; Levy RH; Koester J
    Cornea; 1997 Jul; 16(4):406-13. PubMed ID: 9220237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of autologous serum eye drops with different diluents.
    Cho YK; Huang W; Kim GY; Lim BS
    Curr Eye Res; 2013 Jan; 38(1):9-17. PubMed ID: 22928476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The beneficial effect of diclofenac sodium in the treatment of filamentary keratitis.
    Grinbaum A; Yassur I; Avni I
    Arch Ophthalmol; 2001 Jun; 119(6):926-7. PubMed ID: 11405858
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autologous serum tears: Long-term treatment in dry eye syndrome].
    Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
    J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of corneal biomechanical properties of patients with dry eye secondary to Sjögren's syndrome and healthy subjects.
    Borrego-Sanz L; Sáenz-Francés San Baldomero F; Díaz Valle D; Santos Bueso E; Sánchez Jean R; Martínez de la Casa JM; Benítez Del Castillo JM; García Feijóo J; Rodríguez Rodríguez L
    J Fr Ophtalmol; 2018 Nov; 41(9):802-808. PubMed ID: 30342779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs.
    Guidera AC; Luchs JI; Udell IJ
    Ophthalmology; 2001 May; 108(5):936-44. PubMed ID: 11320025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability and safety of 0.1% diclofenac plus 0.3% tobramycin fixed-dose ophthalmic solution: a randomized, comparative, controlled study in healthy volunteers.
    Salvá P; Costa J; Andreu D; Notivol R; Martínez M
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):203-8. PubMed ID: 10389123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C.
    Levkovitch-Verbin H; Katz G; Kalev-Landoi M; Goldenfeld M
    J Glaucoma; 2013 Mar; 22(3):177-82. PubMed ID: 22027932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
    Marsh P; Pflugfelder SC
    Ophthalmology; 1999 Apr; 106(4):811-6. PubMed ID: 10201607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome.
    Rolando M; Vagge A
    J Ocul Pharmacol Ther; 2017 Jun; 33(5):383-390. PubMed ID: 28375792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.